Notably, our observation that Raldh2 expression is absent in most OPCs within chronic MS lesions, compared to its presence in active lesions and NAWM, suggests that the chronic inactive lesion environment may affect Raldh2 expression in OPCs. Here, ALDH1A2 is linked to myeloid sarcoma.